Bloomberg: "[Ozempic and Wegovy] have sold nearly $50 billion as of the second quarter and are on track to make $65 billion by the end of this year, according to a Bloomberg News analysis .... After adjusting for inflation, that would eclipse the $68 billion that Novo will have spent on all research and development since the mid-1990s..."
Even if the current $1000/mo dropped to $100 in the US this would still be a screaming profit center for them.
rickf - a cynical professor
npub1js…nsxvg
2024-09-23 13:54:53 UTC
Author Public Key
npub1jsjkf7khyrsluvst8facgf25tf5lpsntu7qvscnf222pqcspgc6qxnsxvgSeen on
wss://relay.momostr.pinkPublished at
2024-09-23 13:54:53 UTCEvent JSON
{
"id": "ff769dc6f75e4edbe871d5b950845b26f89ee90ff0c51635609a73d67a97efda",
"pubkey": "942564fad720e1fe320b3a7b8425545a69f0c26be780c8626952941062014634",
"created_at": 1727099693,
"kind": 1,
"tags": [
[
"proxy",
"https://indieweb.social/@rickf/113187205513876177",
"web"
],
[
"proxy",
"https://indieweb.social/users/rickf/statuses/113187205513876177",
"activitypub"
],
[
"L",
"pink.momostr"
],
[
"l",
"pink.momostr.activitypub:https://indieweb.social/users/rickf/statuses/113187205513876177",
"pink.momostr"
],
[
"-"
]
],
"content": "Bloomberg: \"[Ozempic and Wegovy] have sold nearly $50 billion as of the second quarter and are on track to make $65 billion by the end of this year, according to a Bloomberg News analysis .... After adjusting for inflation, that would eclipse the $68 billion that Novo will have spent on all research and development since the mid-1990s...\"\n\nEven if the current $1000/mo dropped to $100 in the US this would still be a screaming profit center for them.",
"sig": "6c4fc4b22e9fbb64113f016ceca1dd4c48c4bba244646f870573fc6ab0c83e2027049e137aa718ddeb7ce00d27ed573ad66608ea8af198698551ffbbb8759db4"
}